WHAT: About 350 people will take part in Saturday’s Vulcan Materials Funshoot, a sporting-clay shooting competition to benefit the Cancer Therapy & Research Center at the UT Health Science Center. Early commitments predict that 2009 will be the year the event breaks the $1.5 million mark during its 16-year history. Funds assist CTRC in its mission to conquer cancer through research, prevention and treatment.
WHEN: Saturday, September 12, 2009. 7 a.m. – 4:30 p.m.
Best time for cover video/interviews is between 1 – 3 p.m. Event will happen rain or shine.
WHERE: National Shooting Complex
5931 Roft Road
San Antonio, TX 78253
WHO: UT System Chancellor Francisco Cigarroa, M.D., and School of Medicine Dean Glenn Halff, M.D., plan to shoot in the second round from 11 a.m. to 2 p.m. can be photographed and interviewed.
J. Thomas Hill, president of Vulcan Materials’ Southwest Division will be available for photos throughout the day. Vulcan employees available for interviews throughout the day are Darren Hicks, Tom McFadden and Oscar Benavides (bilingual).
More than 50 passionate employees and volunteers from Vulcan Materials will be working at the event. A quilt made by employees will be auctioned. Eight Vulcan vendors and clients, the highest number in Funshoot history, bought $5,000 sponsorships. More than 60 other teams paid $1,000 or $2,500 to participate; many are longtime participants.
• 8 a.m. -11 a.m., and 11 a.m.-2 p.m. Sporting clay shooting in two rounds.
• 2:00 – 2:30 p.m. Availability for interviews with UT Health Science Center President William Henrich, M.D. and CTRC Executive Director Tyler Curiel, M.D.
• 2:30-3:00 p.m. Leaders from Vulcan Materials and CTRC speak briefly
• 3:00-4:00 Live Auction and winners of shooting competition announced
Vulcan Materials Company, a member of the S&P 500 Index, is the nation’s largest producer of construction aggregates, a major producer of asphalt mix and concrete and a leading producer of cement in Florida. For more information, visit their Web site at www.vulcanmaterials.com
The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio is one of the nation’s leading academic research and treatment centers, serving more than 4.4 million people in the high-growth corridor of Central and South Texas including Austin, San Antonio, Laredo and the Rio Grande Valley. CTRC is one of a few elite cancer centers in the country to be named a National Cancer Institute (NCI) Designated Cancer Center, and is one of only three in Texas. A world leader in developing new drugs to treat cancer, The CTRC Institute for Drug Development (IDD) is internationally recognized for conducting the largest oncology Phase I clinical drug trials program in the world, and participates in the clinical and/or preclinical development of many of the cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit the Web site at www.ctrc.net